Antibodies for clinical samples
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00668
- Awardee
-
Biolegend, Inc. UEI WVJUG294HEM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,216
Award facts
- Contract value 100% obligated
- $17,215.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Biolegend, Inc. for $17,215.50 on August 20, 2019, for antibodies for clinical samples. Work is performed in San Diego, California, with an ultimate completion date of October 17, 2019. The order carries firm fixed price terms with no set-aside applied.
Quick answers
Who was awarded contract 75N91019P00668?
75N91019P00668 was awarded to Biolegend, Inc. by National Cancer Institute (National Institutes of Health) on August 20, 2019.
How much is contract 75N91019P00668 worth?
The government has obligated $17,216 on 75N91019P00668.
Was contract 75N91019P00668 competed?
The extent of competition for 75N91019P00668 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award